ArticleBriefings in bioinformatics2026
Letter to the editor: testing the generalizability of DeepPlantAllergy on challenging allergen prediction scenarios.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dhouib et al. (DeepPlantAllergy: deep learning for explainable prediction of allergenicity in plant proteins. Brief Bioinform 2025;26:bbaf605.) developed DeepPlantAllergy, a deep learning model for predicting allergenicity in plant proteins, reporting area under the receiver operating characteristic curve (ROC-AUC) ≈ 97.7-97.8% on an independent test set. However, the dataset construction may lead to optimistic performance estimates. Specifically, non-allergen sequences sharing >20% identity with allergens were removed before the train/test split, which can reduce the presence of "hard negatives" (moderately similar non-allergens) in the test set and thereby weaken assessment under realistic screening conditions. Because practical allergen screening requires discrimination against large numbers of non-allergens that may share moderate sequence identity, we suggest re-evaluating the model using test sets that retain challenging negatives (with filtering performed against training allergens only) and reporting precision-recall metrics (area under the precision-recall curve) alongside ROC-AUC to better reflect performance under class imbalance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.